Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: There is an urgent need to identify subjects with Alzheimer’s disease (AD) in the predementia phase, but validated diagnostic approaches are currently lacking. In this paper, we present the background, design and methods of a study, which aims to develop clinical criteria for predementia AD. We also present baseline characteristics of the subjects included. The study was part of the multicentre DESCRIPA project, which is being conducted within the network of the European Alzheimer’s Disease Consortium. Methods: Clinical criteria will be based on a prospective cohort study of non-demented subjects older than 55 years and referred to a memory clinic. At baseline, a number of markers and risk factors for AD were collected, including demographic variables, measures of performance in activities of daily living, cognitive, neuroimaging and genetic markers, and serum and cerebrospinal fluid markers. Subjects will be reassessed annually for 2–3 years, and we will evaluate which combination of variables best predicts AD-type dementia at follow-up. Results: Between 2003 and 2005, 881 subjects were included from 20 memory clinics. Subjects were on average 70.3 years old, and had 10.4 years of education. The average score on the Mini-Mental State Examination was 27.4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Self-citationThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · cited 2×
“MMSE = Mini-Mental State Examination; CDR-SOB = Clinical Dementia Rating scale sum of boxes; APOE = Apolipoprotein E genotype; PreAL = Prediction for Alzheimer’s Disease study [41]; ACCORD = Canadian Collaborative Cohort of Related Dementias study [43]; ITINAD = Italian Interdisciplinary Network on Alzheimer’s disease…”
BackgroundBenedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597 · cited 1×
“Word list of CERAD neuropsychological battery [53] 3 2 centres [54], 1 centre [55] Hopkins Verbal Learning Test [56, 57 ] 3 2 centres [54], 1 centre locally collected norms Grober-Buschke Test [58] 2 [59] ADAS-Cog 10-word list [60] 1 [54]3”
MethodThe Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
The hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317 · cited 1×
“Word list of CERAD neuropsychological battery [53] 3 2 centres [54], 1 centre [55] Hopkins Verbal Learning Test [ 56 , 57] 3 2 centres [54], 1 centre locally collected norms Grober-Buschke Test [58] 2 [59] ADAS-Cog 10-word list [60] 1 [54]3”
MethodWelsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951
Ott, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792
Cited by
Neuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., & Miller, D. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2410 · Cited by 1,139
“The Development of Screening Guidelines and Criteria for Predementia Alzheimer’s disease study is a European collaborative to develop screening guidelines and clinical criteria for early diagnosis of AD [33].”
BackgroundVisser, P. J., Verhey, F., Knol, D. L., Scheltens, P., Wahlund, L.-O., Freund-Levi, Y., Tsolaki, M., Minthon, L., Wallin, Å. K., Hampel, H., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70139-5 · Cited by 614
Self-citationThe Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L., Saykin, A. J., Morris, J. C., Cairns, N., Beckett, L. A., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 599
Slot, R. E. R., Sikkes, S. A. M., Berkhof, J., Brodaty, H., Buckley, R., Cavedo, E., Dardiotis, E., Guillo‐Benarous, F., Hampel, H., Kochan, N. A., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.10.003 · Cited by 428
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
Vos, S. J. B., Verhey, F., Frölich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., Rüther, E., Nobili, F., Morbelli, S., et al. (2015) · Brain · doi:10.1093/brain/awv029 · Cited by 383
Self-citationLombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214
Self-citationTarnanas, I., Schlee, W., Tsolaki, M., Müri, R., Mosimann, U., & Nef, T. (2013) · JMIR Serious Games · doi:10.2196/games.2778 · Cited by 194
“…Verbal Learning Test T (RAVL), Trailmaking Test A (TMT-A), Trailmaking Test B (TMT-B), Trailmaking Test B minus Trailmaking Test A (TMT-B-A), the Bristol ADL scale, and the short form of the Blessed ADL scale for this study because they were evaluated and validated for the Greek population [39].”
Self-citationInjury markers predict time to dementia in subjects with MCI and amyloid pathology
van Rossum, I. A., Vos, S. J. B., Burns, L., Knol, D. L., Scheltens, P., Soininen, H., Wahlund, L.-O., Hampel, H., Tsolaki, M., Minthon, L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182704056 · Cited by 136
Self-citationThe EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Bos, I., Vos, S., Vandenberghe, R., Scheltens, P., Engelborghs, S., Frisoni, G., Molinuevo, J. L., Wallin, A., Lleó, A., Popp, J., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0396-5 · Cited by 112
Self-citationClerx, L., van Rossum, I. A., Burns, L., Knol, D. L., Scheltens, P., Verhey, F., Aalten, P., Lapuerta, P., van de Pol, L., van Schijndel, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.002 · Cited by 98
Self-citationPopuri, K., Ma, D., Wang, L., & Beg, M. F. (2020) · Human Brain Mapping · doi:10.1002/hbm.25115 · Cited by 96
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
ten Kate, M., Redolfi, A., Peira, E., Bos, I., Vos, S. J., Vandenberghe, R., Gabel, S., Schaeverbeke, J., Scheltens, P., Blin, O., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0428-1 · Cited by 78
“Data were obtained from the following cohorts: DESCRIPA [14], EDAR [15], PharmaCog [16] and single-centre studies at VU University Medical Centre [17], San Sebastian GAP [18], University of Antwerp [19], Leuven [20], University of Lausanne [21], University of Gothenburg [22] and Barcelona IDIBAPS [23].”
MethodSelf-citationDamian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000348354 · Cited by 53
Self-citationPreventing cognitive decline in preclinical Alzheimer's disease
Riedel, W. J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.10.002 · Cited by 22
Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study
Chincarini, A., Bosco, P., Gemme, G., Esposito, M., Rei, L., Squarcia, S., Bellotti, R., Minthon, L., Frisoni, G., Scheltens, P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1774 · Cited by 22
Self-citation
Metadata
- Authors
- Visser, P. J., Verhey, F. R. J., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., Frölich, L., Hampel, H., Jolles, J., Jones, R., Minthon, L., Nobili, F., Olde Rikkert, M., Ousset, P.-J., Rigaud, A.-S., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Wahlund, L.-O., Wilcock, G., & Winblad, B.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 30
- Issue
- 4
- Pages
- 254-265
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2102772375
- Cited by
- 84
- References
- 12
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.